Comparative Study of Using Gd-EOB-DTPA and Gd-DTPA As MR Contrast Agent for Hepatic Parenchyma and Vessles Enhacement in the Same Patient with Cirrhosis

张澍杰,饶圣祥,陈锦,李轫晨,陈财忠,曾蒙苏
DOI: https://doi.org/10.13609/j.cnki.1000-0313.2014.07.020
2014-01-01
Abstract:Objective:To evaluate the differences of enhance effects of common hepatic artery (CHA),portal vein (PV)and hepatic parenchyma on dynamic contrast-enhanced (DCE)MRI by using gadolinium ethoxybenzyldiethylenetri-amine pentaacetic acid (Gd-EOB-DTPA)and gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA)separately in the same cirrhotic patient.Methods:The enhanced MR images of liver in 35 cirrhotic patients obtained by using Gd-EOB-DTPA and Gd-DTPA separately in the same patient were reviewed.The percentage enhancement (PE)of CHA,PV and hepatic parenchyma and the relative contrast (RC)between CHA,PV and hepatic parenchyma were calculated and analyzed statisti-cally.Results:The mean PEs of CHA,PV were significantly lower for Gd-EOB-DTPA than Gd-DPTA (P<0.05).The mean PE of hepatic parenchyma at portal phase using Gd-EOB-DTPA was markedly lower than that using Gd-DPTA (P<0.05),whereas there was no significant difference of the mean PE of hepatic parenchyma at arterial phase (P= 0.1010). The RC values of CHA,PV and hepatic parenchyma using Gd-DTPA was slightly higher than that using Gd-EOB-DTPA, yet with no significant statistic difference (P= 0.3421 and 0.2389 respectively).Conclusion:Compared with Gd-DTPA,the enhance effect of Gd-EOB-GTPA was lower in hepatic vessels and hepatic parenchyma in patients with cirrhosis,adjustment of the dosage of Gd-EOB-GTPA should be considered.
What problem does this paper attempt to address?